Ars Technicaarstechnica@mastodon.social
Nov 13, 2026, 10:00 PMMillions in US use unapproved GLP-1s—and use them in unapproved ways
Cost and access barriers are pushing people to modified use and unapproved versions.
https://arstechnica.com/health/2026/11/millions-in-us-use-unapproved-glp-1s-and-use-them-in-unapproved-ways/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
